BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Business

  Paul J. Mirabella, President and CEO of Naviscan PET Systems, Inc., Joins GenVault Corporation’s Board of Directors

  June 12, 2008

   · 

  2 min read
• Drug Development

  ChemoCentryx, Inc. Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohn’s Disease

  June 12, 2008

   · 

  9 min read
• Business

  Albany Molecular Research, Inc. to Receive Second Milestone Payment from Licensing Agreement with Bristol-Myers Squibb Company

  June 12, 2008

   · 

  1 min read
• Business

  Eli Lilly and Company and TransPharma Medical Ltd. Announce Licensing and Development Agreement; TransPharma to Receive $35 Million

  June 12, 2008

   · 

  5 min read
• Sinovac Biotech Ltd. Receives 80,000 Dose Vaccine Order for Earthquake Victims

  June 12, 2008

   · 

  1 min read
• Pharm Country

  Advanced Viral Research Corp. Secures Financing

  June 12, 2008

   · 

  1 min read
• Policy

  KV Pharmaceutical Company Comments on Legal Development in Its Branded Pharmaceutical Business

  June 12, 2008

   · 

  4 min read
• Drug Development

  MethylGene Initiates Second Phase I Clinical Trial With MGCD265, A Multi-Targeted (c-Met) Kinase Inhibitor in Patients With Solid Tumors

  June 12, 2008

   · 

  1 min read
• BioMimetic Therapeutics, Inc. Announces Highlights from Annual Meeting of Stockholders

  June 12, 2008

   · 

  1 min read
• Active Biotech AB’s New Issue Fully Subscribed

  June 12, 2008

   · 

  1 min read